Edition:
United States

Teleflex Inc (TFX.N)

TFX.N on New York Stock Exchange

192.81USD
27 Feb 2017
Change (% chg)

$3.02 (+1.59%)
Prev Close
$189.79
Open
$190.07
Day's High
$193.79
Day's Low
$189.51
Volume
107,179
Avg. Vol
93,967
52-wk High
$193.79
52-wk Low
$136.64

TFX.N

Chart for TFX.N

About

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $8,360.86
Shares Outstanding(Mil.): 44.05
Dividend: 0.34
Yield (%): 0.72

Financials

  TFX.N Industry Sector
P/E (TTM): 38.07 34.59 29.63
EPS (TTM): 4.98 -- --
ROI: 7.13 12.50 12.96
ROE: 11.43 14.56 14.11

BRIEF-Teleflex posts Q4 EPS of $1.29 from continuing operations

* Teleflex reports fourth quarter and full year 2016 results; provides 2017 guidance

Feb 23 2017

BRIEF-Teleflex announces 510(k) clearance and US launch of trapliner catheter

* Teleflex (TFX) announces 510(k) clearance and US launch of trapliner catheter Source text for Eikon: Further company coverage:

Feb 22 2017

BRIEF-Vascular Solutions shareholders approve acquisition by Teleflex

* Vascular Solutions shareholders approve acquisition by Teleflex

Feb 16 2017

BRIEF-Teleflex amends, restates existing credit agreement

* On Jan 20 amended and restated its existing credit agreement, dated as of July 16, 2013- SEC filing

Jan 20 2017

BRIEF-Teleflex receives FDA 510(K) clearance for its Arrow VPS Rhythm(Tm) device

* Teleflex (TFX) receives FDA 510(K) clearance for its Arrow VPS rhythm(tm) device with optional tiptracker(tm) technology Source text for Eikon: Further company coverage:

Jan 10 2017

Medical device maker Teleflex to buy Vascular Solutions for $1 billion

Teleflex Inc said on Friday it agreed to buy fellow medical device maker Vascular Solutions Inc for about $1 billion.

Dec 02 2016

BRIEF-Teleflex Q3 adjusted earnings per share $1.80 from continuing operations

* Reaffirms fy 2016 gaap earnings per share view $5.34 to $5.41 from continuing operations

Oct 27 2016

BRIEF-Teleflex announces European market clearance for its Arrow VPS Rhythm system

* Teleflex announces European market clearance for its Arrow VPS Rhythm system Source text for Eikon: Further company coverage:

Oct 26 2016

BRIEF-Teleflex receives FDA clearance for Arrow Midline with Chlorag+ard Technology

* Has received FDA 510(k) clearance to market its Arrow Midline with Chlorag(+)Ard Technology. Source text for Eikon: Further company coverage:

Oct 17 2016

BRIEF-Teleflex receives FDA clearance for Arrow JACC with Chlorag+ard technology, Tunneler

* Teleflex receives FDA clearance for Arrow JACC with Chlorag+ard technology and Tunneler Source text for Eikon: Further company coverage:

Oct 10 2016

More From Around the Web

Competitors

  Price Chg
C R Bard Inc (BCR.N) $244.24 -0.94
Medtronic PLC (MDT.N) $80.75 -0.28
Becton Dickinson and Co (BDX.N) $182.82 -0.60

Earnings vs. Estimates